Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/REPARE-THERAPEUTICS-INC-108596811/news/Debiopharm-Repare-Therapeutics-geben-die-Verabreichung-des-ersten-Patienten-in-der-Phase-1-1B-Myth-46581370/?utm_source=whatsapp&utm_medium=social&utm_campaign=share